Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Gross-Sondej, J. Soja, G. Pulka, W. Skucha, H. Rybarczyk, A. Gielicz, K. Sladek, E. Nizankowska-Mogilnicka, A. Szczeklik (Cracow, Proszowice, Poland). Bronchospastic eicosanoids in blood and urine of patients with stable and exacerbated COPD. Eur Respir J 2008; 32: Suppl. 52, 3121

Member's Comments

No comment yet.

Related content which might interest you: The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003 COPD patients have reduced bronchial blood flows Source: Eur Respir J 2004; 24: Suppl. 48, 112s Year: 2004 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Magnesium levels in erythrocytes and plasma in patients with exacerbated COPD Source: Eur Respir J 2001; 18: Suppl. 33, 429s Year: 2001 Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Usefulness of daytime arterial blood gases in detection of nocturnal respiratory acidosis in COPD patients undergoing LTOT Source: Eur Respir J 2002; 20: Suppl. 38, 86s Year: 2002 Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 The frequency and the types of arrhythmies of the patients who suffer from COPD and have the disorder if the respiratory gases in the arterial blood Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Temporal effects of analysis delay in arterial blood gas samples in patients with COPD exacerbations and healthy controls Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017